Results 131 to 140 of about 8,109,854 (251)
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley +1 more source
Association between subclinical hypothyroidism and vitamin D deficiency: Insights from a case-control study. [PDF]
Fatemeh A+4 more
europepmc +1 more source
Ð¡ÑŠÑ‰Ð½Ð¾Ñ Ñ‚ и Ð¿Ñ€Ð°ÐºÑ‚Ð¸Ñ‡ÐµÑ ÐºÐ¸ Ð¸Ð·Ð¼ÐµÑ€ÐµÐ½Ð¸Ñ Ð½Ð° Ð»Ð¸Ð´ÐµÑ€Ñ Ñ‚Ð²Ð¾Ñ‚Ð¾ в Ð¼ÐµÐ¶Ð´ÑƒÐ½Ð°Ñ€Ð¾Ð´Ð½Ð¸Ñ Ð¼ÐµÐ½Ð¸Ð´Ð¶Ð¼ÑŠÐ½Ñ‚ [PDF]
СР̧Ð ⁄ ÐμÐ ⁄ Ð ⁄ СР̧Ð ⁄ ÐμÐ ⁄ Ð ⁄ Ð ⁄ Ð
openalex
Analytical Study on Approximate ð-Birkhoff-James Orthogonality
Saied A. Jhonny, Buthainah A. A. Ahmed
openalex +2 more sources
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach+8 more
wiley +1 more source
Diverse biofilm-forming <i>Sphingomonadaceae</i> represent twelve novel species isolated from glaciers on the Tibetan Plateau. [PDF]
Han D, Xin YH, Liu Q.
europepmc +1 more source
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner+6 more
wiley +1 more source
Central Neurophysiological Alterations in Dystrophic mdx Mice Correlate With Reduced Hippocampal Levels of the Endogenous NMDA Receptor Ligand D-Aspartate. [PDF]
Mastrostefano F+6 more
europepmc +1 more source
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva+5 more
wiley +1 more source